PPBT רווחיות גולמית Purple Biotech Ltd

Gross margin on the GURU.Markets consolidated chart for Purple Biotech (PPBT) demonstrates volatility, where 0.00 determines the current value of the indicator. Market reaction is driven by pancreatic cancer therapy trial risks and registration costs. Prospects rely on the efficacy of targeted agents for solid tumors. Currently, Purple Biotech (PPBT) is consuming capital while awaiting test results to create market momentum.
פילוחי מדדים פיננסיים ומדדי שוק עבור purple-biotech.com (PPBT)

For Purple Biotech (PPBT), which develops targeted cancer therapy, the gross margin reflects the efficiency of monetizing innovations after deducting direct drug production costs. This metric is calculated as the ratio of the difference between revenue and cost of goods sold to total sales. By analyzing gross margin trends, an investor assesses the company's ability to control costs, which determines the overall financial stability of the business.